An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021695
Company: LUPIN

Products on NDA 021695

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ANTARA (MICRONIZED)	FENOFIBRATE	43MG	CAPSULE;ORAL	Prescription	AB	Yes	No
ANTARA (MICRONIZED)	FENOFIBRATE	87MG	CAPSULE;ORAL	Discontinued	None	No	No
ANTARA (MICRONIZED)	FENOFIBRATE	130MG	CAPSULE;ORAL	Prescription	AB	Yes	Yes
ANTARA (MICRONIZED)	FENOFIBRATE	30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE;ORAL	Discontinued	None	Yes	No
ANTARA (MICRONIZED)	FENOFIBRATE	90MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE;ORAL	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021695

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
11/30/2004	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021695lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021695ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021695s000_AntaraTOC.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/01/2025	SUPPL-29	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021695s029lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/021695Orig1s029ltr.pdf
07/30/2024	SUPPL-28	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021695s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021695Orig1s028ltr.pdf
06/03/2021	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021695s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021695Orig1s022ltr.pdf
05/15/2019	SUPPL-20	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021695Orig1s020ltr.pdf
11/07/2018	SUPPL-19	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021695Orig1s019ltr.pdf
02/04/2019	SUPPL-18		Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021695Orig1s018ltr.pdf
05/18/2018	SUPPL-17	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021695Orig1s017ltr.pdf
09/11/2017	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021695s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021695Orig1s016ltr.pdf
11/29/2016	SUPPL-14	Manufacturing (CMC)		Label is not available on this site.
11/09/2016	SUPPL-13	Manufacturing (CMC)		Label is not available on this site.
08/31/2015	SUPPL-12	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021695s012lbl.pdf
09/04/2014	SUPPL-11	Manufacturing (CMC)		Label is not available on this site.
12/19/2012	SUPPL-10	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021695Orig1s010ltr.pdf
10/18/2013	SUPPL-9	Manufacturing (CMC)	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021695s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021695Orig1s009ltr.pdf
03/01/2012	SUPPL-8	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021695s008ltr.pdf
06/03/2008	SUPPL-6	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021695s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021695s006ltr.pdf
10/21/2005	SUPPL-1	Efficacy-Labeling Change With Clinical Data	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021695s001ltr.pdf

Labels for NDA 021695

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/01/2025	SUPPL-29	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021695s029lbl.pdf
07/30/2024	SUPPL-28	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021695s028lbl.pdf
06/03/2021	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021695s022lbl.pdf
05/15/2019	SUPPL-20	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s020lbl.pdf
02/04/2019	SUPPL-18	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021695s018lbl.pdf
11/07/2018	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s019lbl.pdf
05/18/2018	SUPPL-17	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021695s017lbl.pdf
09/11/2017	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021695s016lbl.pdf
08/31/2015	SUPPL-12	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021695s012lbl.pdf
10/18/2013	SUPPL-9	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021695s009lbl.pdf
12/19/2012	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s010lbl.pdf
03/01/2012	SUPPL-8	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021695s008lbl.pdf
06/03/2008	SUPPL-6	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021695s006lbl.pdf
11/30/2004	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021695lbl.pdf

Therapeutic Equivalents for NDA 021695

ANTARA (MICRONIZED)

CAPSULE;ORAL; 43MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ANTARA (MICRONIZED)	FENOFIBRATE	43MG	CAPSULE;ORAL	Prescription	Yes	AB	021695	LUPIN
FENOFIBRATE (MICRONIZED)	FENOFIBRATE	43MG	CAPSULE;ORAL	Prescription	No	AB	202252	APOTEX
FENOFIBRATE (MICRONIZED)	FENOFIBRATE	43MG	CAPSULE;ORAL	Prescription	No	AB	090859	CHARTWELL RX

CAPSULE;ORAL; 130MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ANTARA (MICRONIZED)	FENOFIBRATE	130MG	CAPSULE;ORAL	Prescription	Yes	AB	021695	LUPIN
FENOFIBRATE (MICRONIZED)	FENOFIBRATE	130MG	CAPSULE;ORAL	Prescription	No	AB	202252	APOTEX
FENOFIBRATE (MICRONIZED)	FENOFIBRATE	130MG	CAPSULE;ORAL	Prescription	No	AB	090859	CHARTWELL RX

Top